Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Clinician, Consumer",Ferric Carboxymaltose,"Hereditary Haemorrhagic Telangiectasia (HHT), serum ferritin 50 mcg/L or less or transferrin saturation is 20% or less, widening access",Ferric Carboxymaltose (Ferinject),Recommended for decline,Community and Hospital,Blood and Blood Forming Organs
